Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
US Market
Holding APRE?
Track your performance easily

Aprea Therapeutics (APRE) Technical Analysis

443 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Aprea Therapeutics Inc’s (APRE) Moving Averages Convergence Divergence (MACD) indicator is 0.27, suggesting Aprea Therapeutics Inc is a Sell.
Aprea Therapeutics Inc’s (APRE) 20-Day exponential moving average is 3.72, while Aprea Therapeutics Inc’s (APRE) share price is $3.972, making it a Buy.
Aprea Therapeutics Inc’s (APRE) 50-Day exponential moving average is 3.52, while Aprea Therapeutics Inc’s (APRE) share price is $3.972, making it a Buy.

Aprea Therapeutics (APRE) Pivot Points

Nov 05, 2024, 06:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.41
3.62
3.76
3.97
4.11
4.32
4.46
Fibonacci
3.62
3.75
3.83
3.97
4.10
4.18
4.32
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aprea Therapeutics (APRE) Moving Averages

Nov 05, 2024, 06:23 AM
Period
Simple
Exponential
MA5
4.07Sell
4.00Sell
MA10
4.07Sell
3.95Sell
MA20
3.58Buy
3.72Buy
MA50
3.30Buy
3.52Buy
MA100
3.58Buy
3.72Buy
MA200
4.73Sell
4.33Sell
Aprea Therapeutics Inc’s (APRE) 10-Day exponential moving average is 3.95, while Aprea Therapeutics Inc’s (APRE) share price is $3.972, making it a Sell.
Aprea Therapeutics Inc’s (APRE) 100-Day exponential moving average is 3.72, while Aprea Therapeutics Inc’s (APRE) share price is $3.972, making it a Buy.
Aprea Therapeutics Inc’s (APRE) stock price is $3.972 and Aprea Therapeutics Inc’s (APRE) 50-day simple moving average is 3.30, creating a Buy signal.
Aprea Therapeutics Inc’s (APRE) stock price is $3.972 and Aprea Therapeutics Inc’s (APRE) 100-day simple moving average is 3.58, creating a Buy signal.
Aprea Therapeutics Inc’s (APRE) stock price is $3.972 and Aprea Therapeutics Inc’s (APRE) 200-day simple moving average is 4.73, creating a Sell signal.

Aprea Therapeutics (APRE) Technical Indicators

Nov 05, 2024, 06:23 AM
Name
Value
Implied Action
RSI (14)
57.87
Neutral
STOCH (9,6)
14.10
Buy
STOCHRSI (14)
58.73
Neutral
MACD (12,26)
0.27
Sell
ADX (14)
34.04
Neutral
Williams %R
-44.84
Buy
CCI (14)
38.42
Neutral
ATR (14)
0.37
-
Ultimate Oscillator
45.48
Neutral
ROC
53.13
Buy
Aprea Therapeutics Inc’s (APRE) Relative Strength Index (RSI) is 57.87, creating a Neutral signal.
Aprea Therapeutics Inc’s (APRE) Trend Strength Indicator (ADX) is 34.04, creating a Neutral signal.
Aprea Therapeutics Inc’s (APRE) Commodity Channel Index (CCI) is 38.42, creating a Neutral signal.
Aprea Therapeutics Inc’s (APRE) Price Rate of Change (ROC) is 53.13, creating a Buy signal.

FAQ

Is APRE a Buy, Hold, or Sell?
Based on APRE’s technical indicators, APRE is a Buy.
    What is APRE’s RSI (14)?
    APRE’s RSI (14) is 57.87, which suggests APRE is a Neutral.
      What is APRE’s MACD?
      APRE’s MACD is 0.27, which suggests APRE is a Sell.
        What is APRE’s 5-day moving average?
        APRE’s 5-day moving average is 4.07, which suggests APRE is a Sell.
          What is APRE’s 20-day moving average?
          APRE 20-day moving average is 3.58, which suggests APRE is a Buy.
            What is APRE’s 50-day moving average?
            APRE’s 50-day moving average is 3.30, which suggests APRE is a Buy.
              What is APRE’s 200-day moving average?
              APRE’s 200-day moving average is 4.73, which suggests APRE is a Sell.
                What is APRE’s Williams % R (14)?
                APRE’s Williams % R (14) is -44.84, which suggests APRE is a Buy.
                  What is APRE’s CCI (14)?
                  APRE’s CCI (14) is 38.42, which suggests APRE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis